Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Dec;134(6):1249-56.
doi: 10.1017/S0950268806006029. Epub 2006 May 10.

The emerging strains of Shigella dysenteriae type 2 in Bangladesh are clonal

Affiliations

The emerging strains of Shigella dysenteriae type 2 in Bangladesh are clonal

K A Talukder et al. Epidemiol Infect. 2006 Dec.

Abstract

A total of 113 strains of Shigella dysenteriae type 2 isolated from patients attending the Dhaka diarrhoea treatment centre of ICDDR,B: Centre for Health and Population Research during the period 1999-2004 were studied. Serotype of the isolates was confirmed using commercially available antisera. Except for arabinose fermentation, all the strains had similar biochemical reactions. More than 60% of the strains were sensitive to commonly used antibiotics; only 6% (n=7) of the strains were resistant to nalidixic acid, and none of the strains were resistant to mecillinam and ciprofloxacin. All strains were invasive as demonstrated by the presence of a 140 MDa plasmid, ial, sen and ipaH genes, Congo Red absorption ability and by the Sereny test performed on representative strains. Plasmid patterns were heterogeneous but more than 50% of strains were confined to a single pattern. All strains possessed a 1.6 MDa plasmid and 87% of the strains contained a 4 MDa plasmid. Middle-range plasmids (90 MDa to 30 MDa) present in 36% of the strains were not associated with antibiotic resistance. All the strains were clustered within a single type with four subtypes by pulsed-field gel electrophoresis while ribotyping patterns of all the strains were identical.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Agarose gel electrophoresis of plasmid DNA showing the representative patterns among the isolates of S. dysenteriae type 2. Lanes A, B, S. dysenteriae type 2 (pattern P1); lane C, S. dysenteriae type 2 (P2); lane D, S. dysenteriae type 2 (P3); lane E, S. dysenteriae type 2 (P4); lane F, S. dysenteriae type 2 (P5); lane G, S. dysenteriae type 2 (P6); lane H, S. dysenteriae type 2 (P7); lane I, S. dysenteriae type 2 (P8); lane J, S. dysenteriae type 2 (P9); lane K, S. dysenteriae type 2 (P10); lanes L, M, N, E. coli R-1, PDK-9, and V-517 respectively.
Fig. 2
Fig. 2
PFGE banding patterns of NotI-digested chromosomal DNA of representative strains of S. dysenteriae type 2. Lane A, λ ladder (marker); lanes B–L, S. dysenteriae type 2, K-467 (PFGE type A2); K-490 (A1); K-1075 (A1); K-1157 (A1); K-1455 (A3); K-1913 (A1); K-1141 (A1); K-1639 (A4); K-727 (A1); K-1822 (A1); K-1827 (A1) respectively; lane M, λ ladder (marker).
Fig. 3
Fig. 3
Ribotyping patterns of representative strains of S. dysenteriae type 2. Lanes A–M, S. dysenteriae type 2 (K-467, K-490, K-727, K-774, K-1075, K-1083, K-1141, K-1157, K-1158, K-1455, K-1639, K-1827 and KD-11), all strains showed same ribotype (R1).

Similar articles

Cited by

References

    1. Murray CJ, Lopez AD. Mortality by cause for eight reasons of the world: global burden of disease study. Lancet. 1997;349:1269–1276. - PubMed
    1. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet. 1997;349:1436–1442. - PubMed
    1. Melito PL et al. A novel Shigella dysenteriae serovar isolated in Canada. Journal of Clinical Microbiology. 2005;43:740–744. - PMC - PubMed
    1. Kotloff KL et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bulletin of the World Health Organization. 1999;77:651–666. - PMC - PubMed
    1. Ashkenazi S et al. Growing antimicrobial resistance of Shigella isolates. Journal of Antimicrobial Chemotherapy. 2003;512:427–429. - PubMed

Publication types